- Home
- PAAS vs NBIX Comparison
PAAS vs NBIX Comparison
Compare PAAS & NBIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PAAS
- NBIX
- Stock Information
- Founded
- PAAS 1994
- NBIX 1992
- Country
- PAAS Canada
- NBIX United States
- Employees
- PAAS N/A
- NBIX N/A
- Industry
- PAAS
- NBIX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- PAAS
- NBIX Health Care
- Exchange
- PAAS Nasdaq
- NBIX Nasdaq
- Market Cap
- PAAS 15.0B
- NBIX 14.4B
- IPO Year
- PAAS 1995
- NBIX 1996
- Fundamental
- Price
- PAAS $34.93
- NBIX $152.37
- Analyst Decision
- PAAS Strong Buy
- NBIX Strong Buy
- Analyst Count
- PAAS 3
- NBIX 18
- Target Price
- PAAS $45.67
- NBIX $172.06
- AVG Volume (30 Days)
- PAAS 5.9M
- NBIX 1.1M
- Earning Date
- PAAS 11-12-2025
- NBIX 10-28-2025
- Dividend Yield
- PAAS 1.21%
- NBIX N/A
- EPS Growth
- PAAS N/A
- NBIX 12.44
- EPS
- PAAS 1.44
- NBIX 4.19
- Revenue
- PAAS $3,116,300,000.00
- NBIX $2,682,700,000.00
- Revenue This Year
- PAAS $21.54
- NBIX $23.68
- Revenue Next Year
- PAAS $9.98
- NBIX $18.02
- P/E Ratio
- PAAS $28.06
- NBIX $36.35
- Revenue Growth
- PAAS 21.09
- NBIX 19.61
- 52 Week Low
- PAAS $19.80
- NBIX $84.23
- 52 Week High
- PAAS $42.57
- NBIX $157.67
- Technical
- Relative Strength Index (RSI)
- PAAS 43.89
- NBIX 59.16
- Support Level
- PAAS $33.08
- NBIX $133.62
- Resistance Level
- PAAS $36.24
- NBIX $157.67
- Average True Range (ATR)
- PAAS 1.18
- NBIX 4.58
- MACD
- PAAS -0.35
- NBIX 0.98
- Stochastic Oscillator
- PAAS 39.32
- NBIX 67.98
About PAAS Pan American Silver Corp.
Pan American Silver Corp is a mining company principally engaged in the operation and development of, and exploration for, silver and gold-producing properties and assets. The company's principal products are silver and gold, although it also produces and sells zinc, lead, and copper. Its operating mines comprise La Colorada, Dolores, Huaron, Morococha, Shahuindo, La Arena, Timmins West, Bell Creek, Manantial Espejo, and San Vicente mines.
About NBIX Neurocrine Biosciences Inc.
Neurocrine Biosciences Inc engages in the discovery, development, and commercialization of drugs for the treatment of neurological and endocrine-related diseases and disorders in the United States. The company's products include INGREZZA for tardive dyskinesia and chorea associated with Huntington's disease; ALKINDI for adrenal insufficiency; Efmody capsules for classic congenital adrenal hyperplasia; Orilissa tablets for endometriosis; and Oriahnn capsules to treat uterine fibroids.